IIR's GTI seminar is the only US intensive day and a half event that brings together industry thought leaders, genotoxic carcenogenic white paper and FDA guidance authors to define regulatory concerns, build industry best practices, and reduce the need for individual judgment calls. This intensive format designed for you to walk away with a toolkit including everything you need to know about GTIs such as FDA and EU regulatory clarification, toxicology tools to assess GTI's, best practices in determining degradation products,validation criteria for low level impurities, and much, much more.
Event: http://bit.ly/6XeJTa
Agenda: http://bit.ly/5RQW0X
Registration: http://bit.ly/8IEVtW
December 3-4, 2009
Hyatt Regency
Princeton, NJ
Join the event that is building industry best practices for assessing GTI's, specifically focused on process chemistry, stress testing, regulatory concerns and analytical chemistry
Make sure your investment in resources to address GTI concerns are worth it, stay up-to-date with industry trends for limits of genotoxic and potential genotoxic impurities.
Ensure patient safety, clinical initiation and drug approval by learning to detect, identify, and report Genotoxic Impurities
Nothing can replace face to face time with industry peers. This event fosters brainstorming and idea exchange through interactive formats
Hear Current industry thought leaders discuss the validity of the current TTC Limit, where do you stand on the debate? Is the level of conservatism in the TTC approach too high for your drug to be allowed into clinical development?
Share this article with your social network, just click below to share now!
|
|
No comments :
Post a Comment